Anju Software Introduces AI Ecosystem for Rapid Clinical Trial Setup

September 10, 2025
Anju Software has launched clinexa, an AI-powered ecosystem designed to expedite the setup of clinical trials, reducing the timeline from months to days.

Anju Software has introduced clinexa, an AI-driven ecosystem aimed at transforming clinical trial setups, announced in a press release. This innovative platform automates the conversion of clinical protocols into trial-ready databases, significantly reducing the time required from months to just days.

The initial release of clinexa focuses on automating protocol ingestion and generating essential trial components such as casebooks, edit checks, and validation materials. This automation is designed to accelerate the database creation and validation process, enabling sponsors and Contract Research Organizations (CROs) to launch trials more swiftly and concentrate on patient care.

Key benefits of clinexa include a 90% reduction in study build times, a 50% decrease in queries due to NLP-powered edit checks, and a threefold increase in productivity for data managers. The platform ensures data sovereignty, with Anju Software not monetizing customer data.

The introduction of clinexa addresses the costly and time-consuming nature of clinical trial startups, offering a critical edge in quality and compliance for life sciences organizations.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/10
Doceree Introduces AI-Powered RepTwin for Enhanced HCP Engagement
09/10
Kipu Health Appoints Josh Boyer as CFO
09/09
Lilly Introduces AI Platform TuneLab for Biotech Drug Discovery
09/08
Next Ventures Invests in BranchLab for AI-Driven Healthcare Marketing
09/08
Beijing Surgerii's SHURUI Surgical Robot Gains CE Certification

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like